share_log

和鉑醫藥-B：翌日披露報表

HBM HOLDINGS-B: Next Day Disclosure Return

HKEX ·  Sep 12 18:11
Summary by Futu AI
和鉑醫藥控股有限公司（和铂医药-B）於2024年9月12日進行了股份購回活動，根據香港聯合交易所有限公司（香港聯交所）證券上市規則披露。該公司購回了14,000股普通股，每股購回價為1.14港元，總計花費15,960港元。購回後，公司的已發行股份（不包括庫存股份）數目由768,745,410股減少至768,731,410股，而庫存股份數目則增加至145,000股。此次股份購回是根據2024年6月6日獲通過的購回授權進行，並且在購回後的30天內，公司將不會進行任何新股發行或庫存股份再出售或轉讓。執行董事王勁松確認，所有交易均按照規定進行，並無任何重大變動。
和鉑醫藥控股有限公司（和铂医药-B）於2024年9月12日進行了股份購回活動，根據香港聯合交易所有限公司（香港聯交所）證券上市規則披露。該公司購回了14,000股普通股，每股購回價為1.14港元，總計花費15,960港元。購回後，公司的已發行股份（不包括庫存股份）數目由768,745,410股減少至768,731,410股，而庫存股份數目則增加至145,000股。此次股份購回是根據2024年6月6日獲通過的購回授權進行，並且在購回後的30天內，公司將不會進行任何新股發行或庫存股份再出售或轉讓。執行董事王勁松確認，所有交易均按照規定進行，並無任何重大變動。
On September 12, 2024, Hutchison Medicine Holdings Limited (Hutchison Medicine - B) conducted a share repurchase activity, as disclosed in accordance with the listing rules of The Stock Exchange of Hong Kong Limited (HKEx). The company repurchased 14,000 ordinary shares at a repurchase price of HKD 1.14 per share, with a total cost of HKD 15,960. After the repurchase, the number of issued shares (excluding treasury shares) of the company decreased from 768,745,410 shares to 768,731,410 shares, while the number of treasury shares increased to 145,000 shares. This share repurchase was carried out under the repurchase authorization approved on June 6, 2024, and within 30 days after the repurchase, the company will not undertake any issuance of new shares or further sale or transfer of treasury shares. Executive director, Wang Jingsong, confirmed that all transactions were carried out in accordance with regulations and there were no significant changes.
On September 12, 2024, Hutchison Medicine Holdings Limited (Hutchison Medicine - B) conducted a share repurchase activity, as disclosed in accordance with the listing rules of The Stock Exchange of Hong Kong Limited (HKEx). The company repurchased 14,000 ordinary shares at a repurchase price of HKD 1.14 per share, with a total cost of HKD 15,960. After the repurchase, the number of issued shares (excluding treasury shares) of the company decreased from 768,745,410 shares to 768,731,410 shares, while the number of treasury shares increased to 145,000 shares. This share repurchase was carried out under the repurchase authorization approved on June 6, 2024, and within 30 days after the repurchase, the company will not undertake any issuance of new shares or further sale or transfer of treasury shares. Executive director, Wang Jingsong, confirmed that all transactions were carried out in accordance with regulations and there were no significant changes.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.